Synageva BioPharma to Present at Upcoming Investor Conferences

Published: Aug 01, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, will present at the upcoming Wedbush PacGrow LifeSciences Management Access Conference being held in New York City, as well as the Canaccord Genuity 32nd Annual Growth Conference being held in Boston, MA.

Back to news